In Thiamine-Responsive Megaloblastic Anemia (TRMA) syndrome, caused by SLC19A2 mutations, the primary defect is intracellular thiamine deficiency due to transporter failure. Here, SLC19A2 is linked to Thiamine-responsive megaloblastic anemia.